Lung cancer: open trials in Austria

58 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Trial Treatment · Phase 3 · Amgen
Burgenlaendische Krankenanstalten GmbH, Eisenstadt · Medical University of Graz, Graz · Klinikum Klagenfurt Am Woerthersee, Klagenfurt Am Woerthersee · Universitaetsklinikum Krems, Krems An Der Donau · Stadt Wien Wiener Gesundheitsverbund, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels
Registry updated 2026-11-06
NCT06284317
A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
Trial Treatment · Phase 3 · ETOP IBCSG Partners Foundation
Medical University of Vienna, Vienna
Registry updated 2026-11-06
NCT07284121
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Research · Hoffmann-La Roche
Universitatsklinikum Krems, Krems · Ordensklinikum Linz Elisabethinen, Linz · Krankenhaus Nord - Klinik Floridsdorf, Vienna · Klinikum Wels-Grieskirchen, Wels
Registry updated 2026-11-06
NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Medizinische Universitaet Innsbruck, Innsbruck · Ordensklinikum Linz GmbH, Linz · Medical University of Vienna, Vienna
Registry updated 2026-11-05
NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Vorarlberger Krankenhaus-Betriebsgesellschaft mbH, Feldkirch · Ordensklinikum Linz GmbH, Linz · Krankenhaus Nord - Klinik Floridsdorf, Vienna
Registry updated 2026-11-04
NCT06452277
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 3 · Bayer
SCRI CCCIT Ges.m.b.H., Salzburg · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-11-04
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Medizinische Universität Graz, Graz · Ordensklinikum Linz GmbH Elisabethinen, Linz · Klinik Floridsdorf, Vienna
Registry updated 2026-11-04
2022-502959-54-00
A Phase 3, Open-Label, Randomized, Multi-Center Study of DZD9008 versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertion Mutation
Trial Treatment · Phase 3 · Dizal Pharmaceutical Co. Ltd.
Ordensklinikum Linz GmbH, Linz · SCRI CCCIT Ges.m.b.H., Salzburg
Registry updated 2026-11-03
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Medizinische Universitaet Innsbruck, Innsbruck
Registry updated 2026-11-03
NCT07230691
A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
Research · Janssen Research & Development, LLC
University Hospital Graz, Graz · Klinikum Klagenfurt am Worthersee, Klagenfurt · Landeskrankenhaus Hochzirl Natters, Natters
Registry updated 2026-11-03
NCT07365319
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Johannes Kepler University Linz, Linz · Medical University of Vienna, Vienna · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-11-03
NCT07195695
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Trial Treatment · Phase 3 · Boehringer Ingelheim
Medizinische Universitaet Innsbruck, Innsbruck · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-11-02
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Universitaetsklinikum Krems, Krems An Der Donau · Ordensklinikum Linz GmbH, Linz · Klinik Hietzing, Vienna · Medical University of Vienna, Vienna · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-10-30
NCT04928846
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · AbbVie
Vorarlberger Krankenhaus-Betriebsgesellschaft mbH, Feldkirch · Medizinische Universitaet Innsbruck, Innsbruck · Ordensklinikum Linz GmbH, Linz · Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH, Salzburg · Wiener Gesundheitsverbund, Vienna · Medical University of Vienna, Vienna · Krankenhaus Nord - Klinik Floridsdorf, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels
Registry updated 2026-10-29
NCT06422143
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Ordensklinikum Linz GmbH, Linz · Klinik Hietzing, Vienna · Krankenhaus Nord - Klinik Floridsdorf, Vienna · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-10-29
NCT06692738
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · AstraZeneca
Vorarlberger Krankenhaus-Betriebsgesellschaft mbH, Feldkirch · Medizinische Universitaet Innsbruck, Innsbruck · Universitaetsklinikum Krems, Krems An Der Donau · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-10-29
NCT04886804
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
Trial Treatment · Phase 1 · Boehringer Ingelheim
Ordensklinikum Linz GmbH, Linz
Registry updated 2026-10-28
NCT06357533
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Trial Treatment · Phase 3 · AstraZeneca
Vorarlberger Krankenhaus-Betriebsgesellschaft mbH, Feldkirch · Medizinische Universitaet Innsbruck, Innsbruck · Universitaetsklinikum Krems, Krems An Der Donau · Kepler Universitaetsklinikum GmbH, Linz · Krankenhaus Nord - Klinik Floridsdorf, Vienna · Wiener Gesundheitsverbund, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels
Registry updated 2026-10-28
NCT06931717
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy
Trial Treatment · Phase 3 · ETOP IBCSG Partners Foundation
Medical University of Vienna, Vienna
Registry updated 2026-10-28
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Trial Treatment · Phase 3 · Boehringer Ingelheim
Johannes Kepler University Linz, Linz · Ordensklinikum Linz GmbH, Linz · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-10-28
NCT07739966
A Study of DS-3939a in Participants With Solid Tumors
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Medizinische Universität Innsbruck, Innsbruck · Karl Landsteiner Institut Fur Lungenforschung Und Pneumologische Onkologie, Vienna
Registry updated 2026-10-28
NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Trial Treatment · Phase 3 · Mirati Therapeutics Inc.
Medical University of Graz, Graz · Johannes Kepler University Linz, Linz · Stadt Wien Wiener Gesundheitsverbund, Vienna · Medical University of Vienna, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels
Registry updated 2026-10-27
NCT06345729
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Medical University of Graz, Graz · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-10-26
NCT07190248
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Medical University of Graz, Graz · Landeskrankenanstalten-Betriebsgesellschaft Kabeg, Klagenfurt Am Woerthersee · Stadt Wien Wiener Gesundheitsverbund, Vienna
Registry updated 2026-10-26
NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Universitaetsklinikum Krems, Krems An Der Donau · Stadt Wien Wiener Gesundheitsverbund, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels
Registry updated 2026-10-23

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error